Variants in key genes of HR, such as BRCA1, BRCA2, PALB2, BARD1, RAD51C, and RAD51D, which alter their function and/or their expression, have a significant association with breast cancer risk [25,26]. Here, RAD51C is linked to breast carcinoma.